Halozyme elects Dannielle Appelhans to board of directors

HALOZYME THERAPEUTICS, INC.

Dannielle Appelhans elected to Halozyme board on Aug 14, 2026, class with term ending at 2028 annual meeting.
No initial committee assignment; will receive standard non-employee director compensation (cash, RSUs, options).
No arrangements or related-person transactions disclosed in connection with her election.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.